FindTrial
Sign In

The molecular biology mechanism of high dose anisodamine on protecting acute lung injury after thoracotomy

The molecular biology mechanism of high dose anisodamine on protecting acute lung injury after thoracotomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16009954
Enrollment
Unknown
Registered
2016-11-21
Start date
2017-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute lung injury

Interventions

experiment group:Treated with anisodamine after thoracotomy
control group:Treated with normal saline after thoracotomy

Sponsors

First hospital of Xi'an Jiao tong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: The thoracotomy patients in First hospital of Xi'an Jiao tong University

Exclusion criteria

Exclusion criteria: The patients had acute lung injury history, acute cerebral hemorrhage patients and glaucoma patients

Design outcomes

Primary

MeasureTime frame
arterial blood gases;oxygen saturation;—

Countries

China

Contacts

Public ContactDu ning

First hospital of Xi'an Jiao tong University

andrewdu@126.com+86 13571958668

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026